Biosig Technologies, INC 8-K filings

Streamex Corp. announced the resignation of board member Shawn Matthews, effective July 29, 2026, with the company exploring options to fill the vacancy.

Streamex Corp. has dismissed CBIZ CPAs P.C. as its independent auditor and appointed EisnerAmper LLP as its successor.

Streamex Corp. has partnered with Orca to launch a 24/7 decentralized secondary liquidity infrastructure for its gold-backed GLDY token on the Solana blockchain.

Streamex Corp. announced the appointment of Kori Handy, a former lead product designer from Microsoft and PayPal, as its new Vice President of Product and Design.

Streamex Corp. announces executive employment agreement amendments and a new director appointment, detailing compensation, equity awards, and severance.

Streamex Corp. hosted a webcast on April 8, 2026, to discuss its 2025 financial results and provide corporate updates.

Streamex Corp. co-founders Henry McPhie and Morgan Lekstrom have voluntarily entered into one-year lock-up agreements, refuting inaccurate third-party reports.

Streamex Corp. announced the appointment of Christine Plummer, a veteran of Coinbase and Morgan Stanley, as its new Chief Financial Officer, following the resignation of Ferdinand Groenewald.

Streamex Corp. announced the full repayment of its convertible debentures, eliminating debt and dilution overhang, and appointed co-founder Morgan Lekstrom as Executive Chairman.

Streamex Corp. announced the appointment of Anthony Marciano, a finance veteran and NYU Stern professor, as an independent director to its Board and Audit Committee.

Streamex Corp. successfully closed its public offering, including the full exercise of the underwriters' over-allotment option, raising $40.25 million in gross proceeds.

Streamex Corp. announced the termination of its $1 billion Standby Equity Purchase Agreement and the prepayment of $50 million in secured convertible debentures.

Streamex Corp. filed an amended 8-K to correct its prior disclosure, stating that a proposal to classify its board of directors was not duly adopted by stockholders.

Streamex Corp. stockholders approved an increase of 22.5 million shares for its long-term incentive plan and re-elected two Class I directors at its annual meeting.

Streamex Corp. completed a second closing with Yorkville, securing an additional $25 million in convertible debenture financing, bringing gross proceeds of $24 million.

Streamex Corp. has acquired a 9.9% equity interest in Empress Royalty Corp. through a share-for-share transaction valued at US$12.2 million.

Streamex Corp. announced significant leadership changes, including new CEO, CFO, and Chairman appointments, alongside a classified Board structure and detailed executive compensation plans.

Streamex Corp. has closed the first $25 million tranche of its $100 million convertible debenture financing, with all net proceeds immediately deployed into physical allocated gold bullion.

Streamex Corp. stockholders have approved the acquisition of Streamex Exchange Corporation, leading to the issuance of over 109 million shares.

Streamex Corp. announced Nasdaq approval for continued listing and will reconvene a special shareholder meeting on November 4, 2025, to vote on an acquisition proposal.

Streamex Corp. amends its convertible debenture agreement with Yorkville, securing up to $100 million in financing, partially backed by vaulted gold bullion, with significant equity conversion and security provisions.

BioSig Technologies rebrands to Streamex Corp. (STEX), signaling a strategic pivot to Real World Asset tokenization.

BioSig Technologies' StreamEx subsidiary has entered an exclusive, multi-year partnership with Monetary Metals to tokenize yield from precious metal leases, targeting up to 4% annual returns for investors.

BioSig Technologies' stockholders approved significant increases in authorized shares and an incentive plan, while delaying a vote on shares for the Streamex acquisition.

BioSig Technologies, Inc. successfully closed its underwritten public offering, raising approximately $15 million to fund strategic initiatives including gold bullion purchases and Streamex's operational build-out.

BioSig Technologies, Inc. amended its secured convertible debenture purchase agreement with Yorkville, restructuring the financing to include a conversion floor price and mutual agreement for future tranches.

BioSig Technologies, Inc. filed an amended 8-K to provide comprehensive details on its acquisition of Streamex Exchange Corporation, outlining its new blockchain-based real-world asset tokenization business and presenting pro forma financial information.

BioSig Technologies, Inc. has entered into definitive agreements for up to $1.1 billion in growth financing, comprising $100 million in senior secured convertible debentures and a $1 billion standby equity purchase agreement, to advance its real-world asset tokenization platform, particularly for gold and commodities.

BioSig Technologies, Inc. has successfully completed its acquisition of Streamex Exchange Corporation, marking a strategic pivot into real-world asset tokenization and appointing new executive leadership from Streamex.

BioSig Technologies, Inc. has signed a definitive share exchange agreement to acquire Streamex Exchange Corporation, marking a strategic pivot into real-world asset tokenization and commodity markets, accompanied by significant leadership changes and a planned capital raise.